Keep pulling the thread on Bloomberg Businessweek.
OpenAI has stated that over 200 million people use ChatGPT for health and wellness questions each week.
A study published in the medical journal BMJ Open found that AI-driven chatbots provide problematic medical advice approximately 50% of the time.
Dr. Joan Lowry Vare asserts that AI provides a significant opportunity to develop and bring to market new therapies for rare diseases that were previously not possible.
Medical practice regarding menopause is still largely based on the results of the Women's Health Initiative trial, which was published in 2002.
Dr. Joan Lowry Vare states that ambient AI technologies are being used in clinical settings, such as at Boston Children's Hospital, to record patient conversations and create initial drafts of medical notes.
According to Dr. Joan Lowry Vare, women have historically been underrepresented in clinical trials.
Dr. Joan Lowry Vare believes the current era of AI development is a pivotal moment for healthcare, comparable in scale to an industrial revolution.
The UK Biobank is an example of a large-scale dataset that is enabling new potential for AI-driven medical research.
The data from the 2002 Women's Health Initiative trial is based on hormone therapy formulations that are no longer in common use.
Dr. Stephanie Fabian estimates it would cost approximately $200 million to repeat the Women's Health Initiative trial today.
The publication of the Women's Health Initiative trial results in 2002 led to a decline in the use of hormone therapy, resulting in a generation of clinicians not being educated in menopause management.
Dr. Karen Koffler states that insurance companies generally do not cover functional medicine because its in-depth, time-intensive approach does not fit current reimbursement models.